Unknown

Dataset Information

0

An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.


ABSTRACT: Patients with inborn errors of interleukin-17F (IL-17F) or IL-17RA display chronic mucocutaneous candidiasis (CMC). We report a biallelic missense mutation (T536I) in the adaptor molecule ACT1 in two siblings with CMC. The mutation, located in the SEFIR domain, abolished the homotypic interaction of ACT1 with IL-17 receptors, with no effect on homodimerization. The patients' fibroblasts failed to respond to IL-17A and IL-17F, and their T cells to IL-17E. By contrast, healthy individuals homozygous for the common variant D10N, located in the ACT1 tumor necrosis factor receptor-associated factor-interacting domain and previously associated with psoriasis, had impaired, but not abolished, responses to IL-17 cytokines. SEFIR-independent interactions of ACT1 with other proteins, such as CD40, heat shock protein 70 (HSP70) and HSP90, were not affected by the T536I mutation. Overall, human IL-17A and IL-17F depend on ACT1 to mediate protective mucocutaneous immunity. Moreover, other ACT1-dependent IL-17 cytokines seem to be largely redundant in host defense.

SUBMITTER: Boisson B 

PROVIDER: S-EPMC3873857 | biostudies-literature | 2013 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.

Boisson Bertrand B   Wang Chenhui C   Pedergnana Vincent V   Wu Ling L   Cypowyj Sophie S   Rybojad Michel M   Belkadi Aziz A   Picard Capucine C   Abel Laurent L   Fieschi Claire C   Puel Anne A   Li Xiaoxia X   Casanova Jean-Laurent JL  

Immunity 20131010 4


Patients with inborn errors of interleukin-17F (IL-17F) or IL-17RA display chronic mucocutaneous candidiasis (CMC). We report a biallelic missense mutation (T536I) in the adaptor molecule ACT1 in two siblings with CMC. The mutation, located in the SEFIR domain, abolished the homotypic interaction of ACT1 with IL-17 receptors, with no effect on homodimerization. The patients' fibroblasts failed to respond to IL-17A and IL-17F, and their T cells to IL-17E. By contrast, healthy individuals homozygo  ...[more]

Similar Datasets

| S-EPMC3070042 | biostudies-literature
| S-EPMC3580547 | biostudies-literature
| S-EPMC3538358 | biostudies-literature
| S-EPMC9306849 | biostudies-literature
| S-EPMC5192062 | biostudies-literature
| S-EPMC4106025 | biostudies-literature
| S-EPMC3149226 | biostudies-literature
| S-EPMC5056742 | biostudies-literature
| S-EPMC7014825 | biostudies-literature
| S-EPMC3073618 | biostudies-literature